Abstract
Copy number variations of several genes involved in the process of gonadal determination have been identified as a cause of 46,XY differences of sex development. We report a non-syndromic 14-year-old female patient who was referred with primary amenorrhea, absence of breast development, and atypical genitalia. Her karyotype was 47,XY,+mar/46,XY, and FISH analysis revealed the X chromosome origin of the marker chromosome. Array-CGH data identified a pathogenic 2.0-Mb gain of an Xp21.2 segment containing NR0B1/DAX1 and a 1.9-Mb variant of unknown significance from the Xp11.21p11.1 region. This is the first report of a chromosomal microarray analysis to reveal the genetic content of a small supernumerary marker chromosome detected in a 47,XY,+der(X)/46,XY karyotype in a non-syndromic girl with partial gonadal dysgenesis and gonadoblastoma. Our findings indicate that the mosaic presence of the small supernumerary Xp marker, encompassing the NR0B1/DAX1 gene, may have been the main cause of dysgenetic testes development, although the role of MAGEB and other genes mapped to the Xp21 segment could not be completely ruled out.
References
1.
Arn
P
, Chen
H
, Tuck-Muller
CM
, Mankinen
C
, Wachtel
G
, Li
S
, SRVX, a sex reversing locus in Xp21.2→p22.11
. Hum Genet
. 1994
;93
:389
–93
.2.
Bajalica
S
, Blennow
E
, Tsezou
A
, Galla-Voumvouraki
A
, Alevizaki
M
, Sinaniotis
C
, Partial disomy of Xp and the presence of SRY in a phenotypic female
. J Med Genet
. 1995
;32
(12
):987
–90
. .3.
Baker
PR
, Tsai
AC
, Springer
M
, Swisshelm
K
, March
J
, Brown
K
, Male with mosaicism for supernumerary ring X chromosome: analysis of phenotype and characterization of genotype using array comparative genome hybridization
. J Craniofac Surg
. 2010
;21
(5
):1369
–75
. .4.
Barbaro
M
, Oscarson
M
, Schoumans
J
, Staaf
J
, Ivarsson
SA
, Wedell
A
. Isolated 46,XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene
. J Clin Endocrinol Metab
. 2007
;92
(8
):3305
–13
. .5.
Barbaro
M
, Cicognani
A
, Balsamo
A
, Löfgren
A
, Baldazzi
L
, Wedell
A
, Gene dosage imbalances in patients with 46,XY gonadal DSD detected by an in-house-designed synthetic probe set for multiplex ligation-dependent probe amplification analysis
. Clin Genet
. 2008
;73
(5
):453
–64
. .6.
Bardoni
B
, Zanaria
E
, Guioli
S
, Floridia
G
, Worley
KC
, Tonini
G
, A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
. Nat Genet
. 1994
;7
(4
):497
–501
. .7.
Baumstark
A
, Barbi
G
, Djalali
M
, Geerkens
C
, Mitulla
B
, Mattfeldt
T
, Xp-duplications with and without sex reversal
. Hum Genet
. 1996
;97
(1
):79
–86
. .8.
Bernstein
R
, Jenkins
T
, Dawson
B
, Wagner
J
, Dewald
G
, Koo
GC
, Female phenotype and multiple abnormalities in sibs with a Y chromosome and partial X chromosome duplication: H--Y antigen and Xg blood group findings
. J Med Genet
. 1980
;17
(4
):291
–300
. .9.
Dangle
P
, Touzon
MS
, Reyes-Múgica
M
, Witchel
SF
, Rajkovic
A
, Schneck
FX
, Female-to-male sex reversal associated with unique Xp21.2 deletion disrupting genomic regulatory architecture of the dosage-sensitive sex reversal region
. J Med Genet
. 2017
;54
(10
):705
–9
. .10.
Dong
Y
, Yi
Y
, Yao
H
, Yang
Z
, Hu
H
, Liu
J
, Targeted next-generation sequencing identification of mutations in patients with disorders of sex development
. BMC Med Genet
. 2016
;17
:23
. .11.
Fechner
PY
, Marcantonio
SM
, Ogata
T
, Rosales
TO
, Smith
KD
, Goodfellow
PN
, Report of a kindred with X-linked (or autosomal dominant sex-limited) 46,XY partial gonadal dysgenesis
. J Endocrinol Metab
. 1993
;76
:1248
–53
.12.
García-Acero
M
, Molina
M
, Moreno
O
, Ramirez
A
, Forero
C
, Céspedes
C
, Gene dosage of DAX-1, determining in sexual differentiation: duplication of DAX-1 in two sisters with gonadal dysgenesis
. Mol Biol Rep
. 2019
;46
(3
):2971
–8
. .13.
Igarashi
M
, Dung
VC
, Suzuki
E
, Ida
S
, Nakacho
M
, Nakabayashi
K
, Cryptic genomic rearrangements in three patients with 46,XY disorders of sex development
. PLoS One
. 2013
;8
(7
):e68194
. .14.
Ito
S
, Kaino
K
, Hirai
Y
, Kida
Y
, Nakahori
Y
, YN
. A case of XY female with normal SRY
. Oral presentation at the 28th Japanese Society for Paediatric Endocrinology
. 1994
.15.
Jaillard
S
, Bashamboo
A
, Pasquier
L
, Belaud-Rotureau
MA
, McElreavey
K
, Odent
S
, Gene dosage effects in 46,XY DSD: usefulness of CGH technologies for diagnosis
. J Assist Reprod Genet
. 2015
;32
(2
):287
–91
. .16.
Kon
M
, Fukami
M
. Submicroscopic copy-number variations associated with 46,XY disorders of sex development
. Mol Cell Pediatr
. 2015
;2
(1
):7
. .17.
Ledig
S
, Hiort
O
, Scherer
G
, Hoffmann
M
, Wolff
G
, Morlot
S
, Array-CGH analysis in patients with syndromic and non-syndromic XY gonadal dysgenesis: evaluation of array CGH as diagnostic tool and search for new candidate loci
. Hum Reprod
. 2010
;25
(10
):2637
–46
. .18.
Livak
KJ
, Schmittgen
TD
. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
. Methods
. 2001
;25
(4
):402
–8
. .19.
Ludbrook
LM
, Bernard
P
, Bagheri-Fam
S
, Ryan
J
, Sekido
R
, Wilhelm
D
, Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9)
. Endocrinology
. 2012
;153
(4
):1948
–58
. .20.
Mann
JR
, Corkery
JJ
, Fisher
HJ
, Cameron
AH
, Mayerová
A
, Wolf
U
, The X linked recessive form of XY gonadal dysgenesis with a high incidence of gonadal germ cell tumours: clinical and genetic studies
. J Med Genet
. 1983
;20
:264
–70
.21.
May
K
, Grinzaid
K
, Blackston
R
. Sex reversal and multiple abnormalities due to abnormal segregation of T (x-16)(P11. 4-P13. 3)
. Am J Hum Genet
. 1991
;49
:suppl 19:19
.22.
Miller
SA
, Dykes
DD
, Polesky
HF
. A simple salting out procedure for extracting DNA from human nucleated cells
. Nucleic Acids Res
. 1988
;16
(3
):1215
. .23.
Norling
A
, Lindén Hirschberg
A
, Iwarsson
E
, Persson
B
, Wedell
A
, Barbaro
M
. Novel candidate genes for 46,XY gonadal dysgenesis identified by a customized 1 M array-CGH platform
. Eur J Med Genet
. 2013
;56
(12
):661
–8
. .24.
Ogata
T
, Hawkins
J
, Taylor
A
, Matsuo
N
, Hata
J-i
, Goodfellow
PN
. Sex reversal in a child with a 46,X,Yp+ karyotype: support for the existence of a gene(s), located in distal Xp, involved in testis formation
. J Med Gen
. 1992
;29
:226
–30
.25.
Ogata
T
, Matsuo
N
. Sex determining gene on the X chromosome short arm: dosage sensitive sex reversal
. Acta Paediatr Jpn
. 1996
;38
(4
):390
–8
. .26.
Qin
S
, Wang
X
, Li
W
. Genetic analysis of a 46,XY female with sex reversal due to duplication of NR0B1 gene
. Zhonghua Yi Xue Yi Chuan Xue Za Zhi
. 2018
;35
:804
–7
.27.
Sanlaville
D
, Vialard
F
, Thépot
F
, Vue-Droy
L
, Ardalan
A
, Nizard
P
, Functional disomy of Xp including duplication of DAX1 gene with sex reversal due to t(X;Y)(p21.2;p11.3)
. Am J Med Genet A
. 2004
;128a
(3
):325
–30
. .28.
Scherer
G
, Schempp
W
, Baccichetti
C
, Lenzini
E
, Bricarelli
FD
, Carbone
LD
, Duplication of an Xp segment that includes the ZFX locus causes sex inversion in man
. Hum Genet
. 1989
;81
(3
):291
–4
. .29.
Simioni
M
, Lopes Monlleó
I
, Costa de Queiroz
CM
, Fragoso Peixoto Gazzaneo
I
, Lima do Nascimento
DL
, Luna de Omena Filho
R
, A cytogenomic approach in a case of syndromic XY gonadal dysgenesis
. Sex Dev
. 2016
;10
(1
):23
–7
. .30.
Smyk
M
, Berg
JS
, Pursley
A
, Curtis
FK
, Fernandez
BA
, Bien-Willner
GA
, Male-to-female sex reversal associated with an ∼250 kb deletion upstream of NR0B1 (DAX1)
. Hum Genet
. 2007
;122
:63
–70
.31.
Stern
H
, Garrity
A
, Saal
H
, Wangsa
D
, Disteche
C
. Duplication of Xp21 and sex reversal: insight into the mechanism of sex determination
. Am J Hum Genet
. 1990
;47
(Suppl l
):A41
.32.
Sukumaran
A
, Desmangles
JC
, Gartner
LA
, Buchlis
J
. Duplication of dosage sensitive sex reversal area in a 46,XY patient with normal sex determining region of Y causing complete sex reversal
. J Pediatr Endocrinol Metab
. 2013
;26
(7-8
):775
. .33.
Swain
A
, Narvaez
V
, Burgoyne
P
, Camerino
G
, Lovell-Badge
R
. Dax1 antagonizes Sry action in mammalian sex determination
. Nature
. 1998
;391
(6669
):761
–7
. .34.
Vasquez
AI
, Rivera
H
, Mayorquin
A
, Mejia-Baltodano
G
, Escalante
A
, Sanchez-Corona
J
. Sex reversal due to Xp disomy by t(X;Y)(p21;q11)
. Genet Couns
. 1999
;10
:301
–4
.35.
Vetro
A
, Manolakos
E
, Petersen
MB
, Thomaidis
L
, Liehr
T
, Croci
G
, Unexpected results in the constitution of small supernumerary marker chromosomes
. Eur J Med Genet
. 2012
;55
(3
):185
–90
. .36.
Weon
JL
, Potts
PR
. The MAGE protein family and cancer
. Curr Opin Cell Biol
. 2015
;37
:1
–8
. .37.
White
S
, Ohnesorg
T
, Notini
A
, Roeszler
K
, Hewitt
J
, Daggag
H
, Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis
. PLoS One
. 2011
;6
(3
):e17793
. .38.
Yu
S
, Fiedler
SD
, Brawner
SJ
, Joyce
JM
, Zhou
XG
, Liu
HY
. Characterizing small supernumerary marker chromosomes with combination of multiple techniques
. Cytogenet Genome Res
. 2012
;136
(1
):6
–14
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
